2025; 8(2): 802- 808. doi: 10.31488/bjcr.207
Efficacy of the Novel Regimen Pemetrexed-Zanubrutinib in a Patient with Chronic Lymphocytic Leukemia...
- Julia Steger, Jeremy Purow, Tiba Al Sagheer...
2025; 8(2): 802- 808. doi: 10.31488/bjcr.207
Richter’s transformation (RT) is the transformation of chronic lymphocytic...
2025; 8(2): 809- 815. doi: 10.31488/bjcr.208
Background: Socioeconomic inequalities in colorectal cancer (CRC) mortality ....
2025; 8(2): 816- 821. doi: 10.31488/bjcr.209
Background: Disparities exist in all parts of the healthcare continuum. Minority....
2025; 8(3): 822- 826. doi: 10.31488/bjcr.210
Background: The landscape of supportive and palliative care is changing...
2025; 8(3): 827- 831. doi: 10.31488/bjcr.211
Introduction: Cancer patients suffer from a variety of distressing symptoms that affect...
2025; 8(3): 832- 839. doi: 10.31488/bjcr.212
Tobacco, alcohol, and advanced age are well-established risk factors for oral cancer...
Jay W Fox
Professor
Department of Microbiology, Immunology
and Cancer Biology
University of Virginia, USA
British Journal of Cancer Research is an open-access, peer-reviewed international journal dedicated to publishing high-quality research across all areas of oncology. The journal covers cancer prevention, early detection, diagnosis, treatment, survivorship, and patient care.
The journal aims to promote the global exchange of scientific knowledge among basic researchers, translational scientists, and clinicians. It welcomes original research articles, review articles, short communications, case reports, and clinical studies that advance the understanding, prevention, and management of cancer.
You can submit manuscript to British Journal of Cancer Research as Email attachment and expose your work to a wide international audience. Please direct queries on the submission process to the journal’s editorial office.